XCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has appointed Steve Smith as CEO.

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.

Boehringer Ingelheim exercises option to license additional Dark Antigens from a wider array of tumor types, expanding Enara’s eligibility for milestone payments under existing collaboration  Scott ...

The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene ...

Ocean microbes keep the planet healthy by cycling nutrients and capturing carbon, but a detailed and precise map of where ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and refinement of state-of-the-art ML-ready disease models and integration with ...

You won’t want to miss Tour Bowman School at Bayshore! For infants, toddlers, and ages 3-6 years on the Palo Alto Patch ...